Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.23p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22p
  • 52 Week Low: 0.20p
  • Currency: UK Pounds
  • Shares Issued: 2,129.62m
  • Volume: 162,501
  • Market Cap: £4.79m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
58.48% below the market average58.48% below the market average58.48% below the market average58.48% below the market average58.48% below the market average
53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
45.77% above the market average45.77% above the market average45.77% above the market average45.77% above the market average45.77% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Price Book Ratio
49.15% below the market average49.15% below the market average49.15% below the market average49.15% below the market average49.15% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.83% below the market average79.83% below the market average79.83% below the market average79.83% below the market average79.83% below the market average
46.94% below the sector average46.94% below the sector average46.94% below the sector average46.94% below the sector average46.94% below the sector average
Price Chg 3m
96.53% below the market average96.53% below the market average96.53% below the market average96.53% below the market average96.53% below the market average
83.67% below the sector average83.67% below the sector average83.67% below the sector average83.67% below the sector average83.67% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
69.2% below the market average69.2% below the market average69.2% below the market average69.2% below the market average69.2% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Momentum 20
27.79% above the market average27.79% above the market average27.79% above the market average27.79% above the market average27.79% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
90.19% below the market average90.19% below the market average90.19% below the market average90.19% below the market average90.19% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
55.03% below the market average55.03% below the market average55.03% below the market average55.03% below the market average55.03% below the market average
Sector averageSector averageSector averageSector averageSector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
Operating Profit Loss
68.31% below the market average68.31% below the market average68.31% below the market average68.31% below the market average68.31% below the market average
4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
65.75% below the market average65.75% below the market average65.75% below the market average65.75% below the market average65.75% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Cash
44.65% below the market average44.65% below the market average44.65% below the market average44.65% below the market average44.65% below the market average
48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
28.51% below the market average28.51% below the market average28.51% below the market average28.51% below the market average28.51% below the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.23p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22p
52 Week Low 0.20p
Volume 162,501
Shares Issued 2,129.62m
Market Cap £4.79m
Beta 0.01

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.18% below the market average45.18% below the market average45.18% below the market average45.18% below the market average45.18% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Trend
97.15% below the market average97.15% below the market average97.15% below the market average97.15% below the market average97.15% below the market average
95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average
Income Not Available
Growth
16.31% below the market average16.31% below the market average16.31% below the market average16.31% below the market average16.31% below the market average
22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average

Theracryf Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:15 21,551 @ 0.23p
10:26 5,600 @ 0.23p
09:03 2,000 @ 0.25p
09:03 1,752 @ 0.25p
09:03 1,000 @ 0.25p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page